US Food and Drug Administration (FDA) Approval - 17 November 2006
Friday 17 November 2006
Virax gets green light for commencement of Phase II US clinical trials of VIR201.
246 - US Food and Drug Administration (FDA) Approval - 17 November 2006
29 file